Key facts
- NAGE - Niagen Bioscience, Inc. has 21 insiders with reported activity on this page.
- Net insider value flow over the last year: +$45,616.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 21 Insiders of Niagen Bioscience, Inc.
- Symbol
- NAGE on Nasdaq
- Location
- Los Angeles, CA
Change
- Buy value: $45,616; sell value: $0.
- Net share flow: +6,685.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to buying over the last 12 months. Net value: +$45,616.
Buys
$45,616
Shares: 6,685
Insiders: 1
Sells
$0
Shares: 0
Insiders: 0
Net
+$45,616
Shares: +6,685
Insiders: 1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 6,685 | 0 | $45,616 | $0 | +$45,616 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Niagen Bioscience, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Chau Hoi Shuen Solina Holly | 10%+ Owner | $27,205,042 | Mixed | 30 Sep 2022 | ||
| Champion River Ventures Ltd | Director, 10%+ Owner | $16,086,288 | Mixed | 06 Sep 2023 | ||
| Frank L. Jaksch Jr. | Director | $14,351,633 | Mixed | 24 Jun 2025 | ||
| Robert N. Fried | Chief Executive Officer, Director | $7,350,269 | Median | 24 Apr 2026 | ||
| Ozan Pamir | Chief Financial Officer | $65,414 | +$45,616 | +230% | Filing P/S | 19 Feb 2026 |
| Brianna Gerber | Chief Financial Officer | $40,431 | Mixed | 22 Feb 2024 | ||
| Carlos Luis Lopez | SVP, General Counsel | $17,693 | Filing P/S | 19 Feb 2026 | ||
| Li Ka Shing | 10%+ Owner | $0 | Mixed | 06 Sep 2023 | ||
| Kristin Patrick | Director | $0 | Mixed | 24 Jun 2025 | ||
| Stephen A. Block | Director | Mixed | 17 Jun 2021 | |||
| Jeong James Lee | Interim CFO | Mixed | 16 Jul 2024 | |||
| Kurt A. Gustafson | Director | Mixed | 17 Jun 2021 | |||
| Jeff Baxter | Director | Mixed | 17 Jun 2021 | |||
| Tsz Ho Tony Lau | Director | Mixed | 17 Jun 2021 | |||
| Kevin M. Farr | Chief Financial Officer | Mixed | 12 Aug 2022 | |||
| Caroline S. Levy | Director | Mixed | 01 Dec 2021 | |||
| Steven D. Rubin | Director | Mixed | 24 Jun 2025 | |||
| Ann Cohen | Director | Mixed | 24 Jun 2025 | |||
| Wang Yu Gary Ng | Director | Mixed | 24 Jun 2025 | |||
| Wing Tak Wendy Yu | Director | Mixed | 24 Jun 2025 | |||
| Hamed Shahbazi | Director | Mixed | 24 Jun 2025 |
Top shareholders of Niagen Bioscience, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13D/G
|
The Vanguard Group |
4.1%
|
3,286,498
|
$20,902,127 | -$4,675,567 | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.8%
|
3,871,619
|
$17,073,839 | — | 31 Mar 2026 | |
| SteelPeak Wealth, LLC |
13F
|
Company |
4.2%
|
3,373,000
|
$14,874,930 | — | 31 Mar 2026 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
3%
|
2,378,437
|
$10,488,907 | — | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.7%
|
2,149,277
|
$9,478,312 | — | 31 Mar 2026 | |
| Tieton Capital Management, LLC |
13F
|
Company |
2.5%
|
2,029,155
|
$8,949,000 | — | 31 Mar 2026 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
2.1%
|
1,714,639
|
$7,561,558 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
1.8%
|
1,405,531
|
$6,198,392 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
1,344,921
|
$5,933,151 | — | 31 Mar 2026 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.7%
|
1,328,843
|
$5,860,198 | — | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
1,251,959
|
$5,521,139 | — | 31 Mar 2026 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
|
Company |
1.5%
|
1,221,494
|
$5,386,789 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
1,084,565
|
$4,782,932 | — | 31 Mar 2026 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
1,071,133
|
$4,723,181 | — | 31 Mar 2026 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,031,335
|
$4,548,187 | — | 31 Mar 2026 | |
| SEI INVESTMENTS CO |
13F
|
Company |
1.2%
|
971,574
|
$4,284,647 | — | 31 Mar 2026 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.73%
|
582,448
|
$2,568,596 | — | 31 Mar 2026 | |
| Trexquant Investment LP |
13F
|
Company |
0.72%
|
576,816
|
$2,543,759 | — | 31 Mar 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.69%
|
551,349
|
$2,431,449 | — | 31 Mar 2026 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.66%
|
530,477
|
$2,339,404 | — | 31 Mar 2026 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.6%
|
481,442
|
$2,123,160 | — | 31 Mar 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.56%
|
447,359
|
$1,972,853 | — | 31 Mar 2026 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.53%
|
425,422
|
$1,876,111 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.5%
|
396,067
|
$1,746,656 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
0.48%
|
381,089
|
$1,680,602 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.47%
|
374,354
|
$1,650,901 | — | 31 Mar 2026 | |
| OP Asset Management Ltd |
13F
|
Company |
0.42%
|
334,412
|
$1,474,757 | — | 31 Mar 2026 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.41%
|
326,711
|
$1,398,323 | — | 31 Mar 2026 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.4%
|
322,961
|
$2,054,032 | — | 31 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.38%
|
304,718
|
$1,343,806 | — | 31 Mar 2026 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.35%
|
277,381
|
$1,223,250 | — | 31 Mar 2026 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.3%
|
242,411
|
$1,069,032 | — | 31 Mar 2026 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.27%
|
214,685
|
$946,761 | — | 31 Mar 2026 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
191,711
|
$845,447 | — | 31 Mar 2026 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.22%
|
177,010
|
$780,614 | — | 31 Mar 2026 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
0.21%
|
165,000
|
$727,650 | — | 31 Mar 2026 | |
| BSW Wealth Partners |
13F
|
Company |
0.19%
|
154,000
|
$679,140 | — | 31 Mar 2026 | |
| Silverberg Bernstein Capital Management LLC |
13F
|
Company |
0.17%
|
138,102
|
$609,030 | — | 31 Mar 2026 | |
| CREDIT AGRICOLE S A |
13F
|
Individual |
0.16%
|
130,000
|
$573,300 | — | 31 Mar 2026 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.16%
|
125,267
|
$553,000 | — | 31 Mar 2026 | |
| Nuveen, LLC |
13F
|
Company |
0.15%
|
123,270
|
$543,621 | — | 31 Mar 2026 | |
| Quantbot Technologies LP |
13F
|
Company |
0.15%
|
119,673
|
$527,758 | — | 31 Mar 2026 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.13%
|
103,926
|
$458,314 | — | 31 Mar 2026 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.13%
|
103,798
|
$457,749 | — | 31 Mar 2026 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.12%
|
92,343
|
$407,233 | — | 31 Mar 2026 | |
| AVIVA PLC |
13F
|
Company |
0.12%
|
92,121
|
$406,254 | — | 31 Mar 2026 | |
| Creative Planning |
13F
|
Company |
0.1%
|
82,537
|
$363,989 | — | 31 Mar 2026 | |
| Campbell & CO Investment Adviser LLC |
13F
|
Company |
0.1%
|
78,357
|
$345,554 | — | 31 Mar 2026 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.1%
|
76,884
|
$339,059 | — | 31 Mar 2026 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.09%
|
74,490
|
$328,501 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for Niagen Bioscience, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Robert N. Fried | NAGE | Common Stock | Options Exercise | 1.92% | 20,000 | 1,058,981 | 24 Apr 2026 | Direct | ||
| Robert N. Fried | NAGE | Stock Options (right to buy) | Options Exercise | -100% | -20,000 | 0 | 24 Apr 2026 | Direct | ||
| Carlos Luis Lopez | NAGE | Employee Stock Options (right to buy) | Award | 41,420 | 41,420 | 19 Feb 2026 | Direct | |||
| Ozan Pamir | NAGE | Employee Stock Options (right to buy) | Award | 62,131 | 62,131 | 19 Feb 2026 | Direct | |||
| Robert N. Fried | NAGE | Employee Stock Options (right to buy) | Award | 503,937 | 503,937 | 19 Feb 2026 | Direct | |||
| Ozan Pamir | NAGE | Common Stock | Purchase | $15,210 | $6.85 | 2,220 | 2,220 | 14 Nov 2025 | The reported securities are held by the reporting person's spouse. | |
| Ozan Pamir | NAGE | Common Stock | Purchase | 153.6% | $30,406 | $6.81 | 4,465 | 7,372 | 14 Nov 2025 | Direct |
| Hamed Shahbazi | NAGE | Stock Option (right to buy) | Award | 20,000 | 20,000 | 24 Jun 2025 | Direct | |||
| Wing Tak Wendy Yu | NAGE | Stock Option (right to buy) | Award | 20,000 | 20,000 | 24 Jun 2025 | Direct | |||
| Kristin Patrick | NAGE | Stock Option (right to buy) | Award | 20,000 | 20,000 | 24 Jun 2025 | Direct | |||
| Steven D. Rubin | NAGE | Stock Option (right to buy) | Award | 20,000 | 20,000 | 24 Jun 2025 | Direct | |||
| Wang Yu Gary Ng | NAGE | Stock Option (right to buy) | Award | 20,000 | 20,000 | 24 Jun 2025 | Direct | |||
| Ann Cohen | NAGE | Stock Option (right to buy) | Award | 20,000 | 20,000 | 24 Jun 2025 | Direct | |||
| Frank L. Jaksch Jr. | NAGE | Stock Option (right to buy) | Award | 20,000 | 20,000 | 24 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.